Hany Elmariah, MD, discussed the safety profile of fedratinib and its evolving role in the post-transplant setting for patients with myeloproliferative neoplasms.

The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...

CUTTACK: Doctors at the clinical hematology department of SCB medical college and hospital here have successfully conducted ...

The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...

An emotional Ohio State coach Jake Diebler paid tribute to Charley Bauer, who designed his shoes for Coaches vs. Cancer and ...

5, 2024 — Stem cell transplantation is used to treat several ... Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5, 2024 — The first comprehensive ...

Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.

The American Society for Transplantation and Cellular Therapy® (ASTCT®) is pleased to announce David L. Porter, MD, as the ...

Very sick patients who get a bone marrow transplant at Medical University of South Carolina survive at a much higher rate ...